Usability of a Multimodal External Neuromodulatory Device to Relieve Acute Low Back Pain
Addressing Feasibility of the DuoTherm in Acute and Chronic Low Back Pain
2 other identifiers
interventional
20
1 country
1
Brief Summary
Ten patients with acute or chronic low back pain will be invited to try a multimodal device for 20 minutes. Pain will be recorded prior to and after use, and feedback on the device will be elicited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable low-back-pain
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2020
CompletedFirst Submitted
Initial submission to the registry
July 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 18, 2021
CompletedResults Posted
Study results publicly available
October 21, 2022
CompletedOctober 21, 2022
October 1, 2022
1 year
July 28, 2020
August 10, 2022
October 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Pain: Visual Analog Scale (VAS)
Difference in 10 cm VAS printed on paper from 0 (no pain) to 10 (most pain) before and after use of the device, higher value indicates a greater pain reduction, 1.8 cm is considered clinically relevant.
Before use of device (baseline) and after use of device approximately 30 minutes - 20 minutes of use, with 10 minutes for evaluation
Participants' Choice in Thermal Options
One of four options: hot, cold, none, both
30 minutes
Would You Recommend
Binary approval or disapproval of device
After 30 minutes
Secondary Outcomes (1)
Subjective Pain Relief
30 minutes
Study Arms (1)
DuoTherm VibraCool Back Device
EXPERIMENTALPatients will be offered a pain relief belt device incorporating multiple speeds of vibration and optional heat, cold, and pressure delivered through a sculpted metal plate. They will be able to choose from 8 patterns of vibration with the multiple motors (50, 100, 200Hz), and hot or cold, and will wear the device for 20 minutes.
Interventions
Low back plate belt with mechanicothermal and pressure intervention options.
Eligibility Criteria
You may qualify if:
- Acute or chronic low back pain as chief complaint
- Capacity to understand all relevant risks and potential benefits of the study (informed consent);
- Willingness to communicate information
You may not qualify if:
- Radicular pain likely reflecting a surgical or mechanical problem
- BMI greater than 30 (device won't fit)
- Sensitivity to cold or vibration (e.g Raynaud's or Sickle Cell Disease)
- Diabetic neuropathy rendering a patient unable to determine if the device is too hot
- New neurologic deficits
- Skin lesions over the low back area
- Contraindication to any medication for pain management that would impact analgesic use record
- Inability to apply DuoTherm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MMJ Labs LLClead
- National Institute on Drug Abuse (NIDA)collaborator
- Sport and Spine Rehab Clinical Research Foundationcollaborator
Study Sites (1)
Sport and Spine Rehab Clinic
Rockville, Maryland, 20852, United States
Related Publications (7)
Stumbo SP, Yarborough BJ, McCarty D, Weisner C, Green CA. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J Subst Abuse Treat. 2017 Feb;73:47-54. doi: 10.1016/j.jsat.2016.11.003. Epub 2016 Nov 15.
PMID: 28017184BACKGROUNDDarnall BD, Colloca L. Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit. Int Rev Neurobiol. 2018;139:129-157. doi: 10.1016/bs.irn.2018.07.022. Epub 2018 Aug 6.
PMID: 30146045BACKGROUNDDavis CS, Lieberman AJ, Hernandez-Delgado H, Suba C. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review. Drug Alcohol Depend. 2019 Jan 1;194:166-172. doi: 10.1016/j.drugalcdep.2018.09.022. Epub 2018 Nov 3.
PMID: 30445274BACKGROUNDBallard A, Khadra C, Adler S, Trottier ED, Le May S. Efficacy of the Buzzy Device for Pain Management During Needle-related Procedures: A Systematic Review and Meta-Analysis. Clin J Pain. 2019 Jun;35(6):532-543. doi: 10.1097/AJP.0000000000000690.
PMID: 30829735BACKGROUNDLurie RC, Cimino SR, Gregory DE, Brown SHM. The effect of short duration low back vibration on pain developed during prolonged standing. Appl Ergon. 2018 Feb;67:246-251. doi: 10.1016/j.apergo.2017.10.007. Epub 2017 Nov 1.
PMID: 29122196BACKGROUNDUeki S, Yamagami Y, Makimoto K. Effectiveness of vibratory stimulation on needle-related procedural pain in children: a systematic review. JBI Database System Rev Implement Rep. 2019 Jul;17(7):1428-1463. doi: 10.11124/JBISRIR-2017-003890.
PMID: 31021972BACKGROUNDBaxter AL, Thrasher A, Etnoyer-Slaski JL, Cohen LL. Multimodal mechanical stimulation reduces acute and chronic low back pain: Pilot data from a HEAL phase 1 study. Front Pain Res (Lausanne). 2023 Apr 26;4:1114633. doi: 10.3389/fpain.2023.1114633. eCollection 2023.
PMID: 37179530DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Amy Baxter
- Organization
- MMJ Labs
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Baxter, MD
MMJ Labs LLC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 28, 2020
First Posted
July 31, 2020
Study Start
January 17, 2020
Primary Completion
January 20, 2021
Study Completion
February 18, 2021
Last Updated
October 21, 2022
Results First Posted
October 21, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 36 months after publication
- Access Criteria
- researchers providing approved methodologically sound proposals
Individual participant data that underlie the clinical results reported in any publications, after deidentification, will be available for a period of 36 months after publication to achieve approved aims of any researcher who provides a methodologically sound proposal. Proposals should be directed to info@mmjlabs.com. To gain acccess, data requestors will need to sign a data access agreement.